Combination of a dopamine agonist, MAO-B inhibitor and levodopa - a new strategy in the treatment of early Parkinson's disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Parkinsonism
1967 • 11,463 citations
The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease
1989 • 621 citations
The possible mechanisms of action of (-)deprenyl in Parkinson's disease
1978 • 207 citations
Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease
1987 • 168 citations
Low‐dose L‐dopa therapy in Parkinson's disease
1986 • 161 citations
Chronic low‐dose levodopa therapy in Parkinson's disease
1984 • 145 citations
Lisuride, a dopamine agonist in the treatment of early Parkinson's disease
1989 • 131 citations
Monoamines, noyaux gris centraux et syndrome de Parkinson
1975 • 130 citations
Combined bromocriptine-levodopa therapy early in Parkinson's disease
1985 • 115 citations
Problems associated with long-term levodopa treatment of Parkinson's disease
1983 • 95 citations
Selegiline in the treatment of Parkinson's disease
1989 • 56 citations
Deprenyl (selegiline) combined with levodopa and a decarboxylase inhibitor in the treatment of Parkinson's disease
1983 • 49 citations
Treatment of Parkinson's disease: Problems with a progressing disease
1981 • 48 citations
Selegiline as primary treatment in early phase Parkinson's disease - an interim report
1989 • 35 citations
Canine Neurology
1967 • 2 citations